MSB 10.4% $1.49 mesoblast limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-71

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 616 Posts.
    lightbulb Created with Sketch. 142
    growth stalling is not necessarily lack of efficay. I'd say that such a claim would be more in line with substantial decline in sales, not mild/minimal positive growth? so off the bat I'd say that idea hasn't even met your own benchmark of hypothesis generation.

    Market saturation is too hard to say - there was abnormal/substantial growth into the prior comparable periods, which is probably why the current quarters seem restrained growth wise relative to the prior ones (there IS still growth though).

    Pretty odd point to try and pontificate really hard on imo (it's not that odd depending on what your MO is).
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.